Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.
Show notes
(00:31)
Could you provide us a little bit about your background?
(01:20)
Could you give us a brief overview of this assay?
(02:45)
What patients should have this test and when should it be performed?
(04:25)
Could you talk a little bit about alternative test options and how they compare to our ceramides test?
(05:58)
Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?